Jiangsu Hengrui Medicine (600276.SS) Return on Invested Capital (ROIC)

Price: $49.6
Market Cap: $314.93B
Avg Volume: 48.59M
Country: CN
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.425
52W Range: $37.24-57.53
Website: Jiangsu Hengrui Medicine

Return on Invested Capital (ROIC) Summary

Jiangsu Hengrui Medicine 's ROIC measures how effectively the company uses its invested capital to generate profits:

  • Annual: 14.24%
  • Quarterly: 3.93%
  • TTM: 14.05%

What is ROIC?

Return on Invested Capital (ROIC) measures how effectively a company uses its capital from debt and equity to generate profits. ROIC is a useful metric for comparing the efficiency of capital allocation between different companies or across time periods within the same company. A higher ROIC indicates a more efficient use of capital.

Related Metrics

Other important metrics to assess Jiangsu Hengrui Medicine 's profitability include:

  • ROE (Return on Equity) - measures the return generated on shareholders' equity:
    • Annual: 13.92%
    • Quarterly: 3.99%
    • TTM: 15.30%
  • ROA (Return on Assets) - measures the return generated on the company's assets:
    • Annual: 12.64%
    • Quarterly: 3.65%
    • TTM: 13.34%

These metrics provide insights into Jiangsu Hengrui Medicine 's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROIC

14.24%

Quarterly ROIC

3.93%

TTM ROIC

14.05%

Jiangsu Hengrui Medicine Historical ROIC

24.80%24.80%22.32%22.32%19.84%19.84%17.36%17.36%14.88%14.88%12.40%12.40%9.92%9.92%7.44%7.44%4.96%4.96%2.48%2.48%0.00%0.00%ROIC14.24%10.92%10.00%13.06%20.71%21.56%20.88%20.86%20.39%21.27%20162016201720172018201820192019202020202021202120222022202320232024202420252025

Historical ROE

25.15%25.15%22.63%22.63%20.12%20.12%17.60%17.60%15.09%15.09%12.57%12.57%10.06%10.06%7.54%7.54%5.03%5.03%2.51%2.51%0.00%0.00%ROE13.92%10.63%10.33%12.94%20.75%21.51%20.61%20.93%20.90%21.87%20162016201720172018201820192019202020202021202120222022202320232024202420252025

Historical ROA

22.24%22.24%20.01%20.01%17.79%17.79%15.56%15.56%13.34%13.34%11.12%11.12%8.89%8.89%6.67%6.67%4.45%4.45%2.22%2.22%0.00%0.00%ROA12.64%9.83%9.22%11.54%18.22%19.33%18.18%17.83%18.07%18.89%20162016201720172018201820192019202020202021202120222022202320232024202420252025

Jiangsu Hengrui Medicine Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.

Year ROIC ROE ROA
2024 14.24% 13.92% 12.64%
2023 10.92% 10.63% 9.83%
2022 10.00% 10.33% 9.22%
2021 13.06% 12.94% 11.54%
2020 20.71% 20.75% 18.22%
2019 21.56% 21.51% 19.33%
2018 20.88% 20.61% 18.18%
2017 20.86% 20.93% 17.83%
2016 20.39% 20.90% 18.07%
2015 21.27% 21.87% 18.89%

Related Metrics

Explore detailed financial metrics and analysis for 600276.SS.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio